BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16143504)

  • 1. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
    Taylor H; Minger SL
    Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
    Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
    Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midbrain-derived neural stem cells: from basic science to therapeutic approaches.
    Storch A; Sabolek M; Milosevic J; Schwarz SC; Schwarz J
    Cell Tissue Res; 2004 Oct; 318(1):15-22. PubMed ID: 15503150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental perspectives on human midbrain-derived neural stem cells.
    Schwarz J
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S466-8. PubMed ID: 18267285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human pluripotent stem cell and neural differentiation].
    Wataya T; Muguruma K; Sasai Y
    Brain Nerve; 2008 Oct; 60(10):1165-72. PubMed ID: 18975604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The search for a curative cell therapy in Parkinson's disease.
    Laguna Goya R; Tyers P; Barker RA
    J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
    Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
    Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
    Lindvall O; Kokaia Z
    Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
    Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
    Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes.
    Wagner J; Akerud P; Castro DS; Holm PC; Canals JM; Snyder EY; Perlmann T; Arenas E
    Nat Biotechnol; 1999 Jul; 17(7):653-9. PubMed ID: 10404157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells may reshape the prospect of Parkinson's disease therapy.
    Sonntag KC; Simantov R; Isacson O
    Brain Res Mol Brain Res; 2005 Mar; 134(1):34-51. PubMed ID: 15790528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human primordial germ cells and embryonic germ cells, and their use in cell therapy.
    Aflatoonian B; Moore H
    Curr Opin Biotechnol; 2005 Oct; 16(5):530-5. PubMed ID: 16154336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells.
    Ono Y; Nakatani T; Sakamoto Y; Mizuhara E; Minaki Y; Kumai M; Hamaguchi A; Nishimura M; Inoue Y; Hayashi H; Takahashi J; Imai T
    Development; 2007 Sep; 134(17):3213-25. PubMed ID: 17670789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats.
    Ben-Hur T; Idelson M; Khaner H; Pera M; Reinhartz E; Itzik A; Reubinoff BE
    Stem Cells; 2004; 22(7):1246-55. PubMed ID: 15579643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
    Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
    Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restorative approaches in Parkinson's Disease: which cell type wins the race?
    Meyer AK; Maisel M; Hermann A; Stirl K; Storch A
    J Neurol Sci; 2010 Feb; 289(1-2):93-103. PubMed ID: 19733367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal cell replacement in Parkinson's disease.
    Hedlund E; Perlmann T
    J Intern Med; 2009 Oct; 266(4):358-71. PubMed ID: 19765180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient generation of dopaminergic neurons from mouse embryonic stem cells enclosed in hollow fibers.
    Yamazoe H; Iwata H
    Biomaterials; 2006 Oct; 27(28):4871-80. PubMed ID: 16766027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation.
    Fukuda H; Takahashi J; Watanabe K; Hayashi H; Morizane A; Koyanagi M; Sasai Y; Hashimoto N
    Stem Cells; 2006 Mar; 24(3):763-71. PubMed ID: 16223855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.